Covid Winter Plan: Leading scientist ‘doesn’t understand’ delay – Plan B should be NOW
WHO calls for action as Europe coronavirus cases rise We use your sign-up to provide content in ways you’ve consented […]
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This […] The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means it can be difficult for […] MRNA VS. CONVENTIONAL VACCINES Working Together to Empower Women Reducing Health Disparities in Latino Communities Pfizer Women’s Resource Group Universal […] Despite a decrease in reported adverse events after receiving the human papillomavirus (HPV) vaccine, among parents of unvaccinated adolescents, concerns […] Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines […] A recently published study found a marked increase in the number of Australians and New Zealanders turning to digital services for […] Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines […] As a Texan, I’ve been overcome with grief during the past week as our state and much of the country […] GammaDelta Therapeutics Ltd. (GDT), a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for […]Health News
Sharleen Spiteri health: The condition that caused singer’s hair to ‘fall out’
Patients and non-oncology doctors struggle to keep up with the pace of change in oncology
How We’re Partnering to Improve Health Outcomes for Black Youth
HPV Vaccine Safety Concerns Up 80% From 2015 to 2018
Scientists identify new targets for cancer vaccines
Study shows increased use of digital mental health services following COVID-19 in Australia and New Zealand
Study highlights the importance of deeply exploring the immune responses against cancer
I’m a Mother of Color Fighting for Abortion Rights in Texas & Here’s What’s at Stake
GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia